요로 감염 임상진료지침 권고안: 무증상 세균뇨, 단순 요로감염, 복잡성 요로감염, 세균성 전립선염

키워드

참고문헌 (234)

1. Nicolle LE, "Infectious Diseases Society of America; American Society of Nephrology; American Geriatric Society. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults", Clin Infect Dis, 40, pp.643~654 (2005)
2. 신지철, "척수손상 환자에서 증상성 요로감염 시 소변 균주와 항생제 감수성의 변화", Annals of Rehabilitation Medicine, 32(1), pp.38~44 (2008), 대한재활의학회
3. Smaill F, "Antibiotics for asymptomatic bacteriuria in pregnancy", Cochrane Database Syst Rev, (2), pp.CD000490~ (2007)
4. Villar J, "Duration of treatment for asymptomatic bacteriuria during pregnancy", Cochrane Database Syst Rev, (2), pp.CD000491~ (2000)
5. Bayrak O, "Is single-dose fosfomycin trometamol a good alternative for asymptomatic bacteriuria in the second trimesterof pregnancy", Int Urogynecol J Pelvic Floor Dysfunct, 18, pp.525~529 (2007)
6. Tal S, "Profile and prognosis of febrile elderly patients with bacteremic urinary tract infection", J Infect, 50, pp.296~305 (2005)
7. Nicolle LE, "Urinary tract infections in the elderly", Clin Geriatr Med, 25, pp.423~436 (2009)
8. Hedin K, "Asymptomatic bacteriuria in a population of elderly in municipal institutional care", Scand J Prim Health Care, 20, pp.166~168 (2002)
9. Nicolle LE, "Asymptomatic bacteriuria in the elderly", Infect Dis Clin North Am, 11, pp.647~662 (1997)
10. Rodhe N, "Asymptomatic bacteriuria in the elderly: high prevalence and high turnover of strains", Scand J Infect Dis, 40, pp.804~810 (2008)
11. Wing DA, "Daily cranberry juice for the prevention of asymptomatic bacteriuria in pregnancy: a randomized, controlled pilot study", J Urol, 180, pp.1367~1372 (2008)
12. Lumbiganon P, "One-day compared with 7-day nitrofurantoin for asymptomatic bacteriuria in pregnancy: a randomized controlled trial", Obstet Gynecol, 113, pp.339~345 (2009)
13. Harding GK, "Antimicrobial treatment in diabetic women with asymptomatic bacteriuria", N Engl J Med, 347, pp.1576~1583 (2002)
14. Dalal S, "Long-term Escherichia coli asymptomatic bacteriuria among women with diabetes mellitus", Clin Infect Dis, 49, pp.491~497 (2009)
15. Boscia JA, "Therapy vs no therapy for bacteriuria in elderly ambulatory nonhospitalized women", JAMA, 257, pp.1067~1071 (1987)
16. Abrutyn E, "Does asymptomatic bacteriuria predict mortality and does antimicrobial treatment reduce mortality in elderly ambulatory women", Ann Intern Med, 120, pp.827~833 (1994)
17. Nicolle LE, "Bacteriuria in elderly institutionalized men", N Engl J Med, 309, pp.1420~1425 (1983)
18. Nicolle LE, "Prospective randomized comparison of therapy and no therapy for asymptomatic bacteriuria in institutionalized elderly women", Am J Med, 83, pp.27~33 (1987)
19. Ouslander JG, "Does eradicating bacteriuria affect the severity of chronic urinary incontinence in nursing home residents", Ann Intern Med, 12, pp.749~754 (1995)
20. Mohler JL, "Suppression and treatment of urinary tract infection in patients with an intermittently catheterized neurogenic bladder", J Urol, 138, pp.336~340 (1987)
21. Maynard FM, "Urinary infection and complications during clean intermittent catheterization following spinal cord injury", J Urol, 132, pp.943~946 (1984)
22. Harding GK, "How long should catheter-acquired urinary tract infection in women be treated? A randomized controlled study", Ann Intern Med, 114, pp.713~719 (1991)
23. Warren JW, "Cephalexin for susceptible bacteriuria in afebrile, long-term catheterized patients", JAMA, 248, pp.454~458 (1982)
24. Leone M, "A randomized trial of catheter change and short course of antibiotics for asymptomatic bacteriuria in catheterized ICU patients", Intensive Care Med, 33, pp.726~729 (2007)
25. Hooton TM, "Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America", Clin Infect Dis, 50, pp.625~663 (2010)
26. Grabe M, "Controlled trial of a short and a prolonged course with ciprofloxacin in patients undergoing transurethral prostatic surgery", Eur J Clin Microbiol, 6, pp.11~17 (1987)
27. Olsen JH, "Cefotaxime for prevention of infectious complications in bacteriuric men undergoing transurethral prostatic resection. A controlled comparison with methenamine", Scand J Urol Nephrol, 17, pp.299~301 (1983)
28. Grabe M, "The effect of a short antibiotic course in transurethral prostatic resection", Scand J Urol Nephrol, 18, pp.37~42 (1984)
29. Allan WR, "Prophylactic mezlocillin for transurethral prostatectomy", Br J Urol, 57, pp.46~49 (1985)
30. Rao PN, "Prediction of septicemia following endourological manipulation for stones in the upper urinary tract", J Urol, 146, pp.955~960 (1991)
31. Cafferkey MT, "Antibiotics for the prevention of septicaemia in urology", J Antimicrob Chemother, 9, pp.471~477 (1982)
32. Nicolle LE, "Urinary tract infection: traditional pharmacologic therapies", Am J Med, 113(1A), pp.35S~44S (2002)
33. Karlowsky JA, "Fluoroquinolone-resistant urinary isolates of Escherichia coli from outpatients are frequently multidrug resistant: results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance study", Antimicrob Agents Chemother, 50, pp.2251~2254 (2006)
34. Zhanel GG, "Antibiotic resistance in Esc herichiacolioutpatienturinaryisolates:finalresultsfromtheNort hAmericanUrinaryTractInfectionCollaborativeAlliance(NAUT ICA)", IntJAntimicrobAgents, 27, pp.468~475 (2006)
35. 위성헌, "2001년부터 2006년까지 지역사회 획득 급성 신우신장염 여성환자의 임상상 및 원인균의 내성 양상", Infection and Chemotherapy, 49(1), pp.9~16 (2007), 대한감염학회
36. Foxman B, "Acute pyelonephritis in US hospitals in 1997: hospitalization and in-hospital mortality", Ann Epidemiol, 13, pp.144~150 (2003)
37. Vila J, "Are quinolone-resistant uropathogenic Escherichia coli less virulent", J Infect Dis, 186, pp.1039~1042 (2002)
38. Mombelli G, "Oral vs intravenous ciprofloxacin in the initial empirical management of severe pyelonephritis or complicated urinary tract infections: a prospective randomized clinical trial", Arch Intern Med, 159, pp.53~58 (1999)
39. Ramakrishnan K, "Diagnosis and management of acute pyelonephritis in adults", Am Fam Physician, 71, pp.933~942 (2005)
40. Le TP, "Empirical therapy for uncomplicated urinary tract infections in an era of increasing antimicrobial resistance: a decision and cost analysis", Clin Infect Dis, 33, pp.615~621 (2001)
41. Ramakrishnan K, "Diagnosis and management of acute pyelonephritis in adults", Am Fam Physician, 71, pp.933~942 (2005)
42. Warren JW, "Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA)", Clin Infect Dis, 29, pp.745~758 (1999)
43. 기모란, "Antibiotic resistance and pyelonephritis", CLINICAL INFECTIOUS DISEASES, 45, pp.281~283
44. Brown P, "Acute pyelonephritis among adults: cost of illness and considerations for the economic evaluation of therapy", Pharmacoeconomics, 23, pp.1123~1142 (2005)
45. Kim ME, "Prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in female outpatients in South Korea: a multicentre study in 2006", INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 31(1), pp.S15~S18 (2008), ELSEVIER SCIENCE BV
46. 황병연, "서울 강서지역 1개 대학병원에서 성인 급성 신우신염의 원인균과 항생제 감수성", Infection and Chemotherapy, 35(5), pp.277~282 (2003), 대한감염학회
47. Wie SH, "Antibiotic sensitivity of the causative organisms and use of antibiotics in women with community-acquired acute pyelonephritis", Korean J Infect Dis, 34, pp.353~359 (2002)
48. McNulty CA, "Clinical relevance of laboratoryreported antibiotic resistance in acute uncomplicated urinary tract infection in primary care", J Antimicrob Chemother, 58, pp.1000~1008 (2006)
49. Kahlmeter G, "Cross-resistance and associated resistance in 2478 Escherichia coli isolates from the Pan-European ECO.SENS Project surveying the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections", J Antimicrob Chemother, 52, pp.128~131 (2003)
50. Gupta K, "Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: a nationwide analysis", Clin Infect Dis, 33, pp.89~94 (2001)
51. De Backer D, "Evolution of bacterial susceptibility pattern of Escherichia coli in uncomplicated urinary tract infections in a country with high antibiotic consumption: a comparison of two surveys with a 10 year interval", J Antimicrob Chemother, 62, pp.364~368 (2008)
52. Stamm WE, "Measurement of pyuria and its relation to bacteriuria", Am J Med, 75, pp.53~58 (1983)
53. Barry HC, "Evaluation of suspected urinary tract infection in ambulatory women: a cost-utility analysis of office-based strategies", J Fam Pract, 44, pp.49~60 (1997)
54. Tal S, "Profile and prognosis of febrile elderly patients with bacteremic urinary tract infection", J Infect, 50, pp.296~305 (2005)
55. Nicolle LE, "Urinary tract infections in the elderly", Clin Geriatr Med, 25, pp.423~436 (2009)
56. Gleckman R, "Acute pyelonephritis in the elderly", South Med J, 75, pp.551~554 (1982)
57. Kunin CM, "Urinary tract infections in females", Clin Infect Dis, 18, pp.1~12 (1994)
58. Hooton TM, "Amoxicillin-clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women: a randomized trial", JAMA, 293, pp.946~955 (2005)
59. Raz R, "Double-blind study comparing 3-day regimens of cefixime and ofloxacin in treatment of uncomplicated urinary tract infections in women", Antimicrob Agents Chemother, 38, pp.1176~1177 (1994)
60. Talan DA, "Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial", JAMA, 283, pp.1583~1590 (2000)
61. van Merode T, "Acute uncomplicated lower urinary tract infections in general practice: clinical and microbiological cure rates after three- versus five-day treatment with trimethoprim", Eur J Gen Pract, 11, pp.55~58 (2005)
62. Stein GE, "Comparison of three-day temafloxacin with seven-day ciprofloxacin treatment of urinary tract infections in women", J Fam Pract, 34, pp.180~184 (1992)
63. Hooton TM, "Randomized comparative trial and cost analysis of 3-day antimicrobial regimens for treatment of acute cystitis in women", JAMA, 273, pp.41~45 (1995)
64. Gossius G, "A randomised comparison of singledose vs. three-day and ten-day therapy with trimethoprimsulfamethoxazole for acute cystitis in women", Scand J Infect Dis, 16, pp.373~379 (1984)
65. Nicolle LE, "Three days of pivmecillinam or norfloxacin for treatment of acute uncomplicated urinary infection in women", Scand J Infect Dis, 34, pp.487~492 (2002)
66. Richard GA, "Single-dose fluoroquinolone therapy of acute uncomplicated urinary tract infection in women: results from a randomized, double-blind, multicenter trial comparing single-dose to 3-day fluoroquinolone regimens", Urology, 59, pp.334~339 (2002)
67. Vogel T, "Optimal duration of antibiotic therapy for uncomplicated urinary tract infection in older women: a doubleblind randomized controlled trial", CMAJ, 170, pp.469~473 (2004)
68. Bach D, "Rufloxacin once daily versus ciprofloxacin twice daily in the treatment of patients with acute uncomplicated pyelonephritis", J Urol, 154, pp.19~24 (1995)
69. Naber KG, "Gatifloxacin 400 mg as a single shot or 200 mg once daily for 3 days is as effective as ciprofloxacin 250 mg twice daily for the treatment of patients with uncomplicated urinary tract infections", Int J Antimicrob Agents, 23, pp.596~605 (2004)
70. Henry DC Jr, "Comparison of once-daily extended-release ciprofloxacin and conventional twice-daily ciprofloxacin for the treatment of uncomplicated urinary tract infection in women", Clin Ther, 24, pp.2088~2104 (2002)
71. Henry DC, "Comparison of sparfloxacin and ciprofloxacin in the treatment of community-acquired acute uncomplicated urinary tract infection in women. Sparfloxacin Multicenter Uncomplicated Urinary Tract Infection Study Group", Clin Ther, 21, pp.966~981 (1999)
72. Pummer K, "Fleroxacin versus norfloxacin in the treatment of urinary tract infections: a multicenter, double-blind, prospective, randomized, comparative study", Am J Med, 94, pp.108S~113S (1993)
73. Goldstein EJ, "Ciprofloxacin versus cinoxacin in therapy of urinary tract infections. A randomized, double-blind trial", Am J Med, 82, pp.284~287 (1987)
74. Stein GE, "Comparison of three-day temafloxacin with seven-day ciprofloxacin treatment of urinary tract infections in women", J Fam Pract, 34, pp.180~184 (1992)
75. Baker PC, "The addition of ceftriaxone to oral therapy does not improve outcome in febrile children with urinary tract infections", Arch Pediatr Adolesc Med, 155, pp.135~139 (2001)
76. Mombelli G, "Oral vs intravenous ciprofloxacin in the initial empirical management of severe pyelonephritis or complicated urinary tract infections: a prospective randomized clinical trial", Arch Intern Med, 159, pp.53~58 (1999)
77. Sanchez M, "Short-term effectiveness of ceftriaxone single dose in the initial treatment of acute uncomplicated pyelonephritis in women. A randomised controlled trial", Emerg Med J, 19, pp.19~22 (2002)
78. Buchi W, "Experience with parenteral and sequential parenteral-oral amoxicillin", clavulanate (augmentin) in hospitalized patients, 1988, pp.16, 306~312
79. Gok F, "Comparative study of cefixime alone versus intramuscular ceftizoxime followed by cefixime in the treatment of urinary tract infections in children", J Chemother, 13, pp.277~280 (2001)
80. Geerlings SE, "Asymptomatic bacteriuria may be considered a complication in women with diabetes. Diabetes Mellitus Women Asymptomatic Bacteriuria Utrecht Study Group", Diabetes Care, 23, pp.744~749 (2000)
81. Wheat LJ, "Infection and diabetes mellitus", Diabetes Care, 3, pp.187~197 (1980)
82. Geerlings SE, "Effect of glucose and pH on uropathogenic and nonuropathogenic Escherichia coli: studies with urine from diabetic and non-diabetic individuals", J Med Microbiol, 48, pp.535~539 (1999)
83. Zhanel GG, "Prevalence of asymptomatic bacteriuria and associated host factors in women with diabetes mellitus. The Manitoba Diabetic Urinary Infection Study Group", Clin Infect Dis, 21, pp.316~322 (1995)
84. Chen MT, "Percutaneous drainage in the treatment of emphysematous pyelonephritis: 10-year experience", J Urol, 157, pp.1569~1573 (1997)
85. Shokeir AA, "Emphysematous pyelonephritis: a 15-year experience with 20 cases", Urology, 49, pp.343~346 (1997)
86. Kamalian MD, "Emphysematous pyelonephritis caused by candida infection", Southeast Asian J Trop Med Public Health, 36, pp.725~727 (2005)
87. Calvet HM, "Infections in diabetes", Infect Dis Clin North Am, 15, pp.407~421 (2001)
88. Forland M, "Urinary tract infections in patients with diabetes mellitus. Studies on antibody coating of bacteria", JAMA, 238, pp.1924~1926 (1977)
89. Hoepelman AI, "Pathogenesis and management of bacterial urinary tract infections in adult patients with diabetes mellitus", Int J Antimicrob Agents, 22(2), pp.35~43 (2003)
90. Huang JJ, "Emphysematous pyelonephritis: clinicoradiological classification, management, prognosis, and pathogenesis", Arch Intern Med, 160, pp.797~805 (2000)
91. Wan YL, "Acute gas-producing bacterial renal infection: correlation between imaging findings and clinical outcome", Radiology, 198, pp.433~438 (1996)
92. Stamm WE, "Management of urinary tract infections in adults", N Engl J Med, 329, pp.1328~1334 (1993)
93. Meiland R, "Asymptomatic bacteriuria in women with diabetes mellitus: effect on renal function after 6 years of followup", Arch Intern Med, 166, pp.2222~2227 (2006)
94. Park SB, "Outcome of nephrectomy and kidney-preserving procedures for the treatment of emphysematous pyelonephritis", Scand J Urol Nephrol, 40, pp.332~338 (2006)
95. Somani BK, "Is percutaneous drainage the new gold standard in the management of emphysematous pyelonephritis? Evidence from a systemic review", J Urol, 179, pp.1844~1849 (2008)
96. Roy C, "Emphysematous pyelitis: findings in five patients", Radiology, 218, pp.647~650 (2001)
97. Tambyah PA, "Catheter-associated urinary tract infection is rarely symptomatic: a prospective study of 1,497 catheterized patients", Arch Intern Med, 160, pp.678~682 (2000)
98. Nicolle LE, "Consequences of asymptomatic bacteriuria in the elderly", Int J Antimicrob Agents, 4, pp.107~111 (1994)
99. Loeb M, "Development of minimum criteria for the initiation of antibiotics in residents of long-termcare facilities: results of a consensus conference", Infect Control Hosp Epidemiol, 22, pp.120~124 (2001)
100. Anonymous, "The prevention and management of urinary tract infections among people with spinal cord injuries. National Institute on Disability and Rehabilitation Research Consensus Statement. January 27-29, 1992", J Am Paraplegia Soc, 15, pp.194~204 (1992)
101. Tambyah PA, "The relationship between pyuria and infection in patients with indwelling urinary catheters: a prospective study of 761 patients", Arch Intern Med, 160, pp.673~677 (2000)
102. Steward DK, "Failure of the urinalysis and quantitative urine culture in diagnosing symptomatic urinary tract infections in patients with long-term urinary catheters", Am J Infect Control, 13, pp.154~160 (1985)
103. Stephan F, "Reduction of urinary tract infection and antibiotic use after surgery: a controlled, prospective, before-after intervention study", Clin Infect Dis, 42, pp.1544~1551 (2006)
104. Huang WC, "Catheter-associated urinary tract infections in intensive care units can be reduced by prompting physicians to remove unnecessary catheters", Infect Control Hosp Epidemiol, 25, pp.974~978 (2004)
105. Apisarnthanarak A, "Effectiveness of multifaceted hospitalwide quality improvement programs featuring an intervention to remove unnecessary urinary catheters at a tertiary care center in Thailand", Infect Control Hosp Epidemiol, 28, pp.791~798 (2007)
106. Consortium for Spinal Cord Medicine, "Bladder management for adults with spinal cord injury: a clinical practice guideline for health-care providers", J Spinal Cord Med, 29, pp.527~573 (2006)
107. Erickson RP, "Bacteriuria during follow-up in patients with spinal cord injury: I. Rates of bacteriuria in various bladder-emptying methods", Arch Phys Med Rehabil, 63, pp.409~412 (1982)
108. Niel-Weise BS, "Urinary catheter policies for short-term bladder drainage in adults", Cochrane Database Syst Rev, (3), pp.CD004203~ (2005)
109. Kass EH, "Asymptomatic infections of the urinary tract", Trans Assoc Am Physicians, 69, pp.55~64 (1956)
110. Niel-Weise BS, "Antibiotic policies for shortterm catheter bladder drainage in adults", Cochrane Database Syst Rev, (2), pp.CD005428~ (2005)
111. Niel-Weise BS, "Urinary catheter policies for long-term bladder drainage", Cochrane Database Syst Rev, (1), pp.CD004201~ (2005)
112. Rutschmann OT, "Use of norfloxacin for prevention of symptomatic urinary tract infection in chronically catheterized patients", Eur J Clin Microbiol Infect Dis, 14, pp.441~444 (1995)
113. Gribble MJ, "Prophylaxis of urinary tract infection in persons with recent spinal cord injury: a prospective, randomized, double-blind, placebo-controlled study of trimethoprim- sulfamethoxazole", Am J Med, 95, pp.141~152 (1993)
114. van den Broek PJ, "Bladder irrigation with povidone-iodine in prevention of urinary-tract infections associated with intermittent urethral catheterisation", Lancet, 1, pp.563~565 (1985)
115. Ball AJ, "Bladder irrigation with chlorhexidine for the prevention of urinary infection after transurethral operations: a prospective controlled study", J Urol, 138, pp.491~494 (1987)
116. Leone M, "A randomized trial of catheter change and short course of antibiotics for asymptomatic bacteriuria in catheterized ICU patients", Intensive Care Med, 33, pp.726~729 (2007)
117. Warren JW, "Cephalexin for susceptible bacteriuria in afebrile, long-term catheterized patients", JAMA, 248, pp.454~458 (1982)
118. Nicolle LE, "Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults", Clin Infect Dis, 40, pp.643~654 (2005)
119. Nicolle LE, "A practical guide to antimicrobial management of complicated urinary tract infection", Drugs Aging, 18, pp.243~254 (2001)
120. Pearman JW, "The antimicrobial activity of urine of paraplegic patients receiving methenamine mandelate", Invest Urol, 16, pp.91~98 (1978)
121. Raz R, "Chronic indwelling catheter replacement before antimicrobial therapy for symptomatic urinary tract infection", J Urol, 164, pp.1254~1258 (2000)
122. Harding GK, "How long should catheter-acquired urinary tract infection in women be treated? A randomized controlled study", Ann Intern Med, 114, pp.713~719 (1991)
123. Dow G, "A prospective, randomized trial of 3 or 14 days of ciprofloxacin treatment for acute urinary tract infection in patients with spinal cord injury", Clin Infect Dis, 39, pp.658~664 (2004)
124. Wen JG, "Obstructive nephropathy: an update of the experimental research", Urol Res, 27, pp.29~39 (1999)
126. Klahr S, "Obstructive nephropathy", Intern Med, 39, pp.355~361 (2000)
127. Pourmand G, "Urinary infection before and after prostatectomy", Saudi J Kidney Dis Transpl, 21, pp.290~294 (2010)
128. Heidenreich A, "Modern approach of diagnosis and management of acute flank pain: review of all imaging modalities", Eur Urol, 41, pp.351~362 (2002)
129. Jeong MK, "Bacteriological study of urinary tract infections", Korean J Urol, 23, pp.739~744 (1982)
130. Dembry LM, "Renal and perirenal abscesses", Infect Dis Clin North Am, 11, pp.663~680 (1997)
131. Patterson JE, "Bacterial urinary tract infections in diabetes", Infect Dis Clin North Am, 11, pp.735~750 (1997)
132. Nicolle L, "Complicated urinary tract infection in adults", Can J Infect Dis Med Microbiol, 16, pp.349~360 (2005)
133. Tseng TY, "Obstructive uropathy", Clin Geriatr Med, 25, pp.437~443 (2009)
134. Chen MY, "Trends in the use of unenhanced helical CT for acute urinary colic", AJR Am J Roentgenol, 173, pp.1447~1450 (1999)
135. Hamm M, "Unenhanced helical computed tomography in the evaluation of acute flank pain", Eur Urol, 39, pp.460~465 (2001)
136. Miller OF, "Prospective comparison of unenhanced spiral computed tomography and intravenous urogram in the evaluation of acute flank pain", Urology, 52, pp.982~987 (1998)
137. Niall O, "A comparison of noncontrast computerized tomography with excretory urography in the assessment of acute flank pain", J Urol, 161, pp.534~537 (1999)
138. Ruppert-Kohlmayr AJ, "Native spiral computerized tomography in patients with acute flank pain--sense or nonsense", Rofo, 170, pp.168~173 (1999)
139. Bove P, "Reexamining the value of hematuria testing in patients with acute flank pain", J Urol, 162, pp.685~687 (1999)
140. Wang LJ, "Diagnosis of acute flank pain caused by ureteral stones: value of combined direct and indirect signs on IVU and unenhanced helical CT", Eur Radiol, 14, pp.1634~1640 (2004)
141. Rosenstein D, "Urologic emergencies", Med Clin North Am, 88, pp.495~518 (2004)
142. Irwin DE, "Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study", Eur Urol, 50, pp.1306~1315 (2006)
143. Homma Y, "Japanese Society of Neurogenic Bladder. Clinical guideline for male lower urinary tract symptoms", Int J Urol, 16, pp.775~790 (2009)
144. Park HJ, "The role of endourologic management for tuberculous ureteral stricture", Korean J Urol, 42, pp.910~914 (2001)
145. 조수연, "기종성 신우신염의 임상양상 및 사망위험인자", Infection and Chemotherapy, 41(1), pp.30~35 (2009), 대한감염학회
146. Janetschek G, "Percutaneous nephrostomy as a technic for emergency drainage: review of cases", Wien Med Wochenschr, 141, pp.556~559 (1991)
147. Ahn JC, "Percutaneous nephrostomy: experience in 276 cases", Korean J Urol, 35, pp.1248~1253 (1994)
148. Bishop MC, "Urosurgical management of urinary tract infection", J Antimicrob Chemother, 33(A), pp.75~91 (1994)
149. Pontin AR, "Current management of emphysematous pyelonephritis", Nat Rev Urol, 6, pp.272~279 (2009)
150. Thorne MB, "Acute urinary retention in elderly men", Am J Med, 122, pp.815~819 (2009)
151. Rubin RH, "Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Infectious Diseases Society of America and the Food and Drug Administration", Clin Infect Dis, 15(1), pp.S216~S227 (1992)
152. Beck EM, "The fate of residual fragments after extracorporeal shock wave lithotripsy monotherapy of infection stones", J Urol, 145, pp.6~10 (1991)
153. McNeill SA, "Members of the Alfaur Study Group. Alfuzosin once daily facilitates return to voiding in patients in acute urinary retention", J Urol, 171, pp.2316~2320 (2004)
154. Lucas MG, "Tamsulosin in the management of patients in acute urinary retention from benign prostatic hyperplasia", BJU Int, 95, pp.354~357 (2005)
155. McConnell JD, "The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia", N Engl J Med, 349, pp.2387~2398 (2003)
156. Roehrborn CG, "Sustained decrease in incidence of acute urinary retention and surgery with finasteride for 6 years in men with benign prostatic hyperplasia", J Urol, 171, pp.1194~1198 (2004)
157. O'Leary MP, "Improvements in benign prostatic hyperplasia-specific quality of life with dutasteride, the novel dual 5alpha-reductase inhibitor", BJU Int, 92, pp.262~266 (2003)
158. Brosnahan J, "Types of urethral catheters for management of short-term voiding problems in hospitalised adults", Cochrane Database Syst Rev, (1), pp.CD004013~ (2004)
159. AUA Practice Guidelines Committee, "AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations", J Urol, 170, pp.530~547 (2003)
160. Ramsey S, "Evidence-based drainage of infected hydronephrosis secondary to ureteric calculi", J Endourol, 24, pp.185~189 (2010)
161. Selius BA, "Urinary retention in adults: diagnosis and initial management", Am Fam Physician, 77, pp.643~650 (2008)
162. 이승환, "The Urologist’s View of Male Overactive Bladder: Discrepancy between Reality and Belief in Practical Setting", Yonsei Medical Journal, 51(3), pp.432~437 (2010), 연세대학교의과대학
163. Nyman MA, "Management of urinary retention: rapid versus gradual decompression and risk of complications", Mayo Clin Proc, 72, pp.951~956 (1997)
164. Uppot RN, "Emergent nephrostomy tube placement for acute urinary obstruction", Tech Vasc Interv Radiol, 12, pp.154~161 (2009)
165. Bierer S, "Obstructive uropathy in adults", Aktuelle Urol, 36, pp.329~336 (2005)
166. Kim SC, "A clinical observation on 131 cases of hydronephrosis", Korean J Urol, 19, pp.89~97 (1978)
167. Weidner W, "Altmannsberger M. Chronic prostatitis: a thorough search for etiologically involved microorganisms in 1,461 patients", Infection, 19(3), pp.S119~S125 (1991)
168. Schneider H, "The 2001 Giessen Cohort Study on patients with prostatitis syndrome--an evaluation of inflammatory status and search for microorganisms 10 years after a first analysis", Andrologia, 35, pp.258~262 (2003)
169. Ronald A, "The etiology of urinary tract infection: traditional and emerging pathogens", Am J Med, 113(1A), pp.14S~19S (2002)
170. Bichler KH, "Urinary infection stones", Int J Antimicrob Agents, 19, pp.488~498 (2002)
171. Romero Culleres G, "Characteristics of urinary tract infections in different patient subpopulations and depending on the bladder emptying system", Actas Urol Esp, 34, pp.251~257 (2010)
172. Barros M, "Enterococcal urinary tract infections in a university hospital: clinical studies", Braz J Infect Dis, 13, pp.294~296 (2009)
173. Johansen TE, "Hospital acquired urinary tract infections in urology departments: pathogens, susceptibility and use of antibiotics. Data from the PEP and PEAP-studies", Int J Antimicrob Agents, 28(1), pp.S91~S107 (2006)
174. Kumazawa J, "Complicated urinary tract infection, in Urinary tract infections: molecular pathogenesis and clinical management", pp.19~26 (1997), Karger
175. Chevalier RL, "Therapeutic approaches in obstructive uropathy", Semin Nephrol, 18, pp.652~658 (1998)
176. Nicolle LE, "A practical guide to the management of complicated urinary tract infection", Drugs, 53, pp.583~592 (1997)
177. McNaughton-Collins M, "Managing patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia", Am J Med, 118, pp.1331~1339 (2005)
178. Irani J, "A review of guidelines on benign prostatic hyperplasia and lower urinary tract symptoms: are all guidelines the same", BJU Int, 92, pp.937~942 (2003)
179. 오철용, "Korean Urologist’s View of Practice Patterns in Diagnosis and Management of Benign Prostatic Hyperplasia: A Nationwide Survey", Yonsei Medical Journal, 51(2), pp.248~252 (2010), 연세대학교의과대학
180. DasGupta R, "Evidence-based prescription of antibiotics in urology: a 5-year review of microbiology", BJU Int, 104, pp.760~764 (2009)
181. 황선덕, "급성신우신염 환자에서 균혈증의 위험 인자 분석 - 단일기관 분석", Kidney Research and Clinical Practice, 28(5), pp.418~423 (2009), 대한신장학회
182. 김경영, "최근 2년간 전라남도 및 광주지역의 지역사회 획득성 요로감염에 이환된 여성 환자에서 동정된 Escherichia coli의 Ciprofloxacin 내성패턴", Korean Journal of Urology, 49(6), pp.540~548 (2008), 대한비뇨기과학회
183. Segura JW, "Staghorn calculi", Urol Clin North Am, 24, pp.71~80 (1997)
184. Emori TG, "An overview of nosocomial infections, including the role of the microbiology laboratory", Clin Microbiol Rev, 6, pp.428~442 (1993)
185. Wells WG, "Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy", J Antimicrob Chemother, 53(2), pp.ii67~ii74 (2004)
186. Pietrow PK, "Evaluation and medical management of urinary lithiasis, in Campbell-Walsh Urology" (2007), WB Saunders Elsevier
187. 김현우, "전립선비대증에서 나타나는 조직학적 염증소견의 의미", Korean Journal of Urology, 50(2), pp.154~158 (2009), 대한비뇨기과학회
188. Schaeffer AJ, "The assessment and management of male pelvic pain syndrome, including prostatitis, in Male lower uninary tract dysfunction, evaluation and management; 6th international consultation on new developments in prostate cancer and prostate disease", pp.341~385 (2006), Health Publications
189. Weidner W, "Chronic prostatitis: a thorough search for etiologically involved microorganisms in 1,461 patients", Infection, 19(3), pp.S119~S125 (1991)
190. Nickel JC, "Asymptomatic inflam24 mation and", or infection in benign prostatic hyperplasia, 1999, pp.84, 976~981
191. Nelson WG, "The role of inflammation in the pathogenesis of prostate cancer", J Urol, 172, pp.S6~S11 (2004)
192. Krieger JN, "NIH consensus definition and classification of prostatitis", JAMA, 282, pp.236~237 (1999)
193. Millan-Rodriguez F, "Villavicencio- Mavrich H. Acute bacterial prostatitis: two different subcategories according to a previous manipulation of the lower urinary tract", World J Urol, 24, pp.45~50 (2006)
194. Ha US, "Acute bacterial prostatitis in Korea: clinical outcome, including symptoms, management, microbiology and course of disease", INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 31(1), pp.S96~S101 (2008)
195. 조수연, "급성세균성전립선염의 임상적 특징 및 치료 결과", Infection and Chemotherapy, 41(1), pp.36~41 (2009), 대한감염학회
196. 조인래, "급성 세균성 전립선염 환자의 임상적 경과", Korean Journal of Urology, 46(10), pp.1034~1039 (2005), 대한비뇨기과학회
197. Brook I, "Urinary tract and genito-urinary suppurative infections due to anaerobic bacteria", Int J Urol, 11, pp.133~141 (2004)
198. Naber KG, "Management of bacterial prostatitis: what's new", BJU Int, 101(3), pp.7~10 (2008)
199. Nickel JC, "Chronic bacterial prostatitis; An evolving clinical enigma", Urology, 66, pp.2~8 (2005)
200. Bundrick W, "Levofloxacin versus ciprofloxacin in the Treatment of Chronic Bacterial Prostatitis: A randomised double-blind multicenter study", Urology, 62, pp.537~541 (2003)
201. Pewitt EB, "Urinary tract infection in urology, including acute and chronic prostatitis", Infect Dis Clin North Am, 11, pp.623~646 (1997)
202. Leigh DA, "Prostatitis - an increasing clinical problem for diagnosis and management", J Antimicrob Chemother, 32(A), pp.1~9 (1993)
203. Meares EM Jr, "Acute and chronic prostatitis: diagnosis and treatment", Infect Dis Clin North Am, 1, pp.855~873 (1987)
204. Ludwig M, "Diagnosis and therapy of acute prostatitis, epididymitis and orchitis", Andrologia, 40, pp.76~80 (2008)
205. Kravchick S, "Acute prostatitis in middle-aged men: a prospective study", BJU Int, 93, pp.93~96 (2004)
206. Meares EM, "Bacteriologic localization patterns in bacterial prostatitis and urethritis", Invest Urol, 5, pp.492~518 (1968)
207. Etienne M, "Acute bacterial prostatitis: heterogeneity in diagnostic criteria and management. Retrospective multicentric analysis of 371 patients diagnosed with acute prostatitis", BMC Infect Dis, 8, pp.12~ (2008)
208. Schaeffer AJ, "Prostatitis: US perspective", Int J Antimicrob Agents, 11, pp.205~211 (1999)
209. Meares EM Jr, "Prostatic abscess", J Urol, 136, pp.1281~1282 (1986)
210. Paulson DF, "Trimethoprim-sulfamethoxazole and minocycline-hydrochloride in the treatment of culture-proved bacterial prostatitis", J Urol, 120, pp.184~185 (1978)
211. Meares EM, "Long-term therapy of chronic bacterial prostatitis with trimethoprim-sulfamethoxazole", Can Med Assoc J, 112, pp.22~25 (1975)
212. McGuire EJ, "Bacterial prostatitis: treatment with trimethoprim- sulfamethoxazole", Urology, 7, pp.499~500 (1976)
213. Bjerklund Johansen TE, "The role of antibiotics in the treatment of chronic prostatitis: a consensus statement", Eur Urol, 34, pp.457~466 (1998)
214. Wagenlehner FM, "Prostatitis: the role of antibiotic treatment", World J Urol, 21, pp.105~108 (2003)
215. Naber KG, "Antibiotic treatment of chronic bacterial prostatitis, in Textbook of Prostatitis", pp.285~292 (1999), Isis Medical Media
216. Malinverni R, "Comparative studies of fluoroquinolones in the treatment of urinary tract infections", Rev Infect Dis, 10(1), pp.S153~S163 (1988)
217. Naber KG, "Use of quinolones in urinary tract infections and prostatitis", Rev Infect Dis, 11(5), pp.S1321~S1337 (1989)
218. Naber KG, "Ciprofloxacin in the treatment of chronic bacterial prosatatitis: A prospective, non-comparative multicentre clinical trial with long-term follow-up. The German Prostatitis Study Group", Int J Antimicrobial Agents, 14, pp.143~149 (2000)
219. Bundrick W, "Levofloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis: a randomized double-blind multicenter study", Urology, 62, pp.537~541 (2003)
220. Naber KG, "European Lomefloxacin Prostatitis Study Group. Lomefloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis", Int J Antimicrob Agents, 20, pp.18~27 (2002)
221. Giannarini G, "Prulifloxacin versus levofloxacin in the treatment of chronic bacterial prostatitis: a prospective, randomized, double-blind trial", J Chemother, 19, pp.304~308 (2007)
222. Bjerklund Johansen TE, "Palou Redorta J, van Cangh PJ. The role of antibiotics in the treatment of chronic prostatitis: a consensus statement", Eur Urol, 34, pp.457~466 (1998)
223. Kurzer E, "Cost effectiveness model comparing trimethoprim sulfamethoxazole and ciprofloxacin for the treatment of chronic bacterial prostatits", Eur Urol, 42, pp.163~166 (2002)
224. 오창수, "만성 전립선염에 대한 Levofloxacin의 경구 치료효과", Infection and Chemotherapy, 37(2), pp.99~104 (2005), 대한감염학회
225. Park RJ, "The Efficacy of Oral Ciprofloxacin in the Treatment of Patients with Chronic Prostatitis", J Korean Soc Chemother, 17, pp.229~238 (1999)
226. Pust RA, "Clinical efficacy of ofloxacin (tarivid) in patients with chronic bacterial prostatitis: preliminary results", J Chemother, 1(4), pp.869~871 (1989)
227. Weidner W, "Treatment of chronic bacterial prostatitis with ciprofloxacin. Results of a one-year follow-up study", Am J Med, 82, pp.280~283 (1987)
228. Peppas T, "Efficacy of long-term therapy with norfloxacin in chronic bacterial prostatitis", J Chemother, 1(4), pp.867~868 (1989)
229. Pfau A, "The treatment of chronic bacterial prostatitis", Infection, 19(3), pp.S160~S164 (1991)
230. Frazier HA, "Total prostatoseminal vesiculectomy in the treatment of debilitating perineal pain", J Urol, 148, pp.409~411 (1992)
231. 이건철, "Transurethral needle ablation for chronic nonbacterial prostatitis", BJU INTERNATIONAL, 89, pp.226~229 (2002), BLACKWELL PUBLISHING
232. Skerk V, "Comparative analysis of azithromycin and clarithromycin efficacy and tolerability in the treatment of chronic prostatitis caused by Chlamydia trachomatis", J Chemother, 14, pp.384~389 (2002)
233. Skerk V, "Comparative analysis of azithromycin and ciprofloxacin in the treatment of chronic prostatitis caused by Chlamydia trachomatis", Int J Antimicrob Agents, 21, pp.457~462 (2003)
234. Skerk V, "Comparative randomized pilot study of azithromycin and doxycycline efficacy in the treatment of prostate infection caused by Chlamydia trachomatis", Int J Antimicrob Agents, 24, pp.188~191 (2004)

관련 논문AI추천